Orrin Hatch said...

It should come as no surprise that many of us on the committee have concerns about the process, effects, and strategy be...

What else is the FDA going to do to alleviate these shortages, and prevent future shortages from disrupting the practice...

To me, this so-called administration blueprint looks less like a blueprint than it does like blue smoke and mirrors.

I have since spearheaded numerous other legislative initiatives to address shortcomings in the system and to capitalize ...